ATF6: Activating Transcription Factor 6 – Key Regulator of the Unfolded Protein Response
Comprehensive gene card for ATF6, including genomic annotations, expression data, disease associations, and functional classification.
Gene Information Card
| Symbol | ATF6 |
|---|---|
| Full Name | Activating Transcription Factor 6 |
| Gene Type | Protein coding |
| Chromosomal Location | 1q23.3 |
| NCBI Gene ID | 22926 ncbi.nlm.nih.gov/gene/22926 |
| Ensembl ID | ENSG00000118217 |
| UniProt ID | P18850 |
| OMIM ID | 605537 |
| HGNC ID | 791 |
| Aliases | ATF6A, ATF6B, CREB3L1, CREB3L2 |
Description
ATF6 (Activating Transcription Factor 6) encodes a transcription factor that is a key mediator of the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. Under normal conditions, ATF6 is retained in the ER membrane bound to BiP/GRP78. Upon ER stress, ATF6 translocates to the Golgi apparatus where it is cleaved by site-1 and site-2 proteases, releasing its cytosolic N-terminal domain. This active fragment then enters the nucleus and upregulates genes involved in protein folding, ER-associated degradation (ERAD), and lipid biosynthesis. ATF6 is essential for cellular homeostasis and its dysregulation is implicated in various diseases including cancer, neurodegeneration, and metabolic disorders.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Achromatopsia | Loss-of-function mutations in ATF6 impair the UPR in cone photoreceptors, leading to cell death | ClinVar; PMID: 26063662 |
| Retinitis pigmentosa | ATF6 variants disrupt ER stress response in retinal cells | ClinVar; PMID: 26063662 |
| Cancer (breast, colorectal) | ATF6 overexpression promotes tumor survival under hypoxia and ER stress | COSMIC; PMID: 28263307 |
| Diabetes mellitus type 2 | ATF6-mediated UPR dysfunction contributes to pancreatic beta-cell apoptosis | OMIM; PMID: 19151718 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Liver | 12.5 | Medium |
| Pancreas | 8.3 | Low |
| Brain | 6.7 | Low |
| Heart | 5.2 | Low |
| Kidney | 9.1 | Low |
| Testis | 15.8 | Medium |
| Retina | 22.4 | High |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK293 | 18.2 | Embryonic kidney cells |
| HeLa | 14.7 | Cervical cancer cells |
| HepG2 | 11.3 | Hepatocellular carcinoma cells |
| MCF7 | 9.8 | Breast cancer cells |
| ARPE-19 | 21.5 | Retinal pigment epithelial cells |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1240C>T (p.Arg414Cys) | Missense | Rare | Impaired cleavage and nuclear translocation; associated with achromatopsia |
| c.1618G>A (p.Gly540Arg) | Missense | Rare | Reduced transcriptional activity; linked to retinitis pigmentosa |
| c.1975_1976del (p.Leu659fs) | Frameshift | Rare | Loss of function; truncation of C-terminal domain |
Mutation functional classification
Loss of Function (LOF)
Missense and frameshift mutations that impair ATF6 cleavage, nuclear translocation, or DNA binding lead to loss of UPR transcriptional activation.
Gain of Function (GOF)
Not well documented; overexpression in cancer may confer gain-of-function by enhancing survival under ER stress.
Dominant Negative (DN)
Some missense variants (e.g., p.Arg414Cys) may act in a dominant-negative manner by forming non-functional dimers with wild-type ATF6.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Unfolded Protein Response (UPR) – Reactome R-HSA-381119
• ATF6-alpha activates chaperones – Reactome R-HSA-381038
• ER stress and the UPR – KEGG hsa04141
Protein Summary
ATF6 is a 670-amino acid transmembrane protein localized to the endoplasmic reticulum. It contains a basic leucine zipper (bZIP) domain in its N-terminal cytosolic region and a luminal domain that senses ER stress. Upon ER stress, ATF6 is transported to the Golgi and cleaved by S1P and S2P proteases, releasing a 50 kDa active transcription factor that translocates to the nucleus. The active form binds to ER stress response elements (ERSE) to upregulate chaperones (e.g., BiP, GRP94) and ERAD components. ATF6 is ubiquitously expressed with highest levels in retina, testis, and liver.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| ATF6B Knockout HEK293 Cell Line | EDJ-KQ764 | Human | 1388 | Details Get a Quote |
| ATF6 Knockout HEK293 Cell Line | EDJ-KQ2861 | Human | 22926 | Details Get a Quote |
| ATF6B Knockout HeLa Cell Line | EDJ-KQ17957 | Human | 1388 | Details Get a Quote |
| ATF6B Knockout A-549 Cell Line | EDJ-KQ19452 | Human | 1388 | Details Get a Quote |
| ATF6B Knockout HCT 116 Cell Line | EDJ-KQ19453 | Human | 1388 | Details Get a Quote |
| ATF6 Knockout A-549 Cell Line | EDJ-KQ25263 | Human | 22926 | Details Get a Quote |
| ATF6 Knockout HCT 116 Cell Line | EDJ-KQ25265 | Human | 22926 | Details Get a Quote |
| ATF6 Knockout HeLa Cell Line | EDJ-KQ25266 | Human | 22926 | Details Get a Quote |
Displaying Records 1 To 8 Of 8 Records